Trichopus Zeylanicus - Vumerity (Diroximel Fumarate) Interaction

Interaction Details

Diroximel Fumarate is classified as belonging to the following category: Immunosuppressants

Theoretically, Trichopus zeylanicus might reduce the effects of immunosuppressants. Animal research suggests that Trichopus zeylanicus might have immunostimulant effects.

Interaction Rating

Likelihood of Occurrence

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists

References

• Singh B, Chandan BK, Sharma N, et al. Adaptogenic activity of glyco-peptido-lipid fraction from the alcoholic extract of Trichopus zeylanicus Gaerten (part II). Phytomedicine 2005;12:468-81.

Diroximel Fumarate Overview

• Diroximel fumarate is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including:

• • clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours),

  • relapsing-remitting forms (course of disease where symptoms flare up from time to time), or

  • secondary progressive forms (course of disease where relapses occur more often).

• Diroximel fumarate is in a class of medications called Nrf2 activators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.

Trichopus Zeylanicus - More Interactions

Trichopus Zeylanicus interacts with 111 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.